Tissue functions mediated by beta3-adrenoceptors-Findings and challenges

Martin Michel, Peter Ochodnicky, Roger Summers

Research output: Contribution to journalArticleResearchpeer-review

Abstract

As I?3-adrenoceptor agonists metamorphose from experimental tools into therapeutic drugs, it is vital to obtain a comprehensive picture of the cell and tissue functions mediated by this receptor subtype in humans. Human tissues with proven functions and/or a high expression of I?3-adrenoceptors include the urinary bladder, the gall bladder, and other parts of the gastrointestinal tract. While several other I?3-adrenoceptor functions have been proposed based on results obtained in animals, their relevance to humans remains uncertain. For instance, I?3-adrenoceptors perform an important role in thermogenesis and lipolysis in rodent brown and white adipose tissue, respectively, but their role in humans appears less significant. Moreover, the use of tools such as the agonist BRL 37344 and the antagonist SR59230A to demonstrate functional involvement of I?3-adrenoceptors may lead in many cases to misleading conclusions as they can also interact with other I?-adrenoceptor subtypes or even non-adrenoceptor targets. In conclusion, we propose that many responses attributed to I?3-adrenoceptor stimulation may need re-evaluation in the light of the development of more selective tools. Moreover, findings in experimental animals need to be extended to humans in order to better understand the potential additional indications and side effects of the I?3-adrenoceptor agonists that are beginning to enter clinical medicine.
Original languageEnglish
Pages (from-to)103 - 108
Number of pages6
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume382
Issue number2
DOIs
Publication statusPublished - 2010

Cite this

@article{4b6648f17d124b2cb2fdfb4ee7211a1c,
title = "Tissue functions mediated by beta3-adrenoceptors-Findings and challenges",
abstract = "As I?3-adrenoceptor agonists metamorphose from experimental tools into therapeutic drugs, it is vital to obtain a comprehensive picture of the cell and tissue functions mediated by this receptor subtype in humans. Human tissues with proven functions and/or a high expression of I?3-adrenoceptors include the urinary bladder, the gall bladder, and other parts of the gastrointestinal tract. While several other I?3-adrenoceptor functions have been proposed based on results obtained in animals, their relevance to humans remains uncertain. For instance, I?3-adrenoceptors perform an important role in thermogenesis and lipolysis in rodent brown and white adipose tissue, respectively, but their role in humans appears less significant. Moreover, the use of tools such as the agonist BRL 37344 and the antagonist SR59230A to demonstrate functional involvement of I?3-adrenoceptors may lead in many cases to misleading conclusions as they can also interact with other I?-adrenoceptor subtypes or even non-adrenoceptor targets. In conclusion, we propose that many responses attributed to I?3-adrenoceptor stimulation may need re-evaluation in the light of the development of more selective tools. Moreover, findings in experimental animals need to be extended to humans in order to better understand the potential additional indications and side effects of the I?3-adrenoceptor agonists that are beginning to enter clinical medicine.",
author = "Martin Michel and Peter Ochodnicky and Roger Summers",
year = "2010",
doi = "10.1007/s00210-010-0529-2",
language = "English",
volume = "382",
pages = "103 -- 108",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer-Verlag London Ltd.",
number = "2",

}

Tissue functions mediated by beta3-adrenoceptors-Findings and challenges. / Michel, Martin; Ochodnicky, Peter; Summers, Roger.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 382, No. 2, 2010, p. 103 - 108.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Tissue functions mediated by beta3-adrenoceptors-Findings and challenges

AU - Michel, Martin

AU - Ochodnicky, Peter

AU - Summers, Roger

PY - 2010

Y1 - 2010

N2 - As I?3-adrenoceptor agonists metamorphose from experimental tools into therapeutic drugs, it is vital to obtain a comprehensive picture of the cell and tissue functions mediated by this receptor subtype in humans. Human tissues with proven functions and/or a high expression of I?3-adrenoceptors include the urinary bladder, the gall bladder, and other parts of the gastrointestinal tract. While several other I?3-adrenoceptor functions have been proposed based on results obtained in animals, their relevance to humans remains uncertain. For instance, I?3-adrenoceptors perform an important role in thermogenesis and lipolysis in rodent brown and white adipose tissue, respectively, but their role in humans appears less significant. Moreover, the use of tools such as the agonist BRL 37344 and the antagonist SR59230A to demonstrate functional involvement of I?3-adrenoceptors may lead in many cases to misleading conclusions as they can also interact with other I?-adrenoceptor subtypes or even non-adrenoceptor targets. In conclusion, we propose that many responses attributed to I?3-adrenoceptor stimulation may need re-evaluation in the light of the development of more selective tools. Moreover, findings in experimental animals need to be extended to humans in order to better understand the potential additional indications and side effects of the I?3-adrenoceptor agonists that are beginning to enter clinical medicine.

AB - As I?3-adrenoceptor agonists metamorphose from experimental tools into therapeutic drugs, it is vital to obtain a comprehensive picture of the cell and tissue functions mediated by this receptor subtype in humans. Human tissues with proven functions and/or a high expression of I?3-adrenoceptors include the urinary bladder, the gall bladder, and other parts of the gastrointestinal tract. While several other I?3-adrenoceptor functions have been proposed based on results obtained in animals, their relevance to humans remains uncertain. For instance, I?3-adrenoceptors perform an important role in thermogenesis and lipolysis in rodent brown and white adipose tissue, respectively, but their role in humans appears less significant. Moreover, the use of tools such as the agonist BRL 37344 and the antagonist SR59230A to demonstrate functional involvement of I?3-adrenoceptors may lead in many cases to misleading conclusions as they can also interact with other I?-adrenoceptor subtypes or even non-adrenoceptor targets. In conclusion, we propose that many responses attributed to I?3-adrenoceptor stimulation may need re-evaluation in the light of the development of more selective tools. Moreover, findings in experimental animals need to be extended to humans in order to better understand the potential additional indications and side effects of the I?3-adrenoceptor agonists that are beginning to enter clinical medicine.

UR - http://www.springerlink.com/content/kv737338qv18424n/

U2 - 10.1007/s00210-010-0529-2

DO - 10.1007/s00210-010-0529-2

M3 - Article

VL - 382

SP - 103

EP - 108

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 2

ER -